Linde India (LINDEINDIA)
StalwartFairStock Score: 45/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹6,696 |
| Market Cap | ₹57,106.31 Cr |
| P/E Ratio | 104.17 |
| ROCE | 16.9% |
| ROE | 15.44% |
| Dividend Yield | 0.06% |
| Profit Growth | -1.94% |
| Debt/Equity | 0.02 |
| Sales Growth | 21.7% |
| Free Cash Flow | ₹-721 Cr |
| Promoter Holding | 75% |
| 52-Week Range | ₹5,673 — ₹8,049 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹500.27 |
Strengths
- Near-zero debt with D/E of 0.02 and a fortress-like balance sheet (Altman Z-Score 8.57).
- High return ratios: ROE of 15.44% and ROCE of 16.90%.
- Promoter holding of 75% aligns majority ownership with minority investors.
- Piotroski F-Score of 8/9 indicates strong financial health and earnings quality.
- Five-year revenue CAGR of 11.06% demonstrates a solid long-term growth track record.
Concerns
- Extremely expensive valuation: P/E of 98.35 and P/B of 16.32, far above Graham Number of ₹825.88.
- Negative margin of safety of -714.89% at the current price.
- Sales growth of -0.61% despite profit growth of 34.39%, suggesting margin-driven rather than revenue-driven earnings.
- Free cash flow is negative at ₹721 Cr despite reported profit, and dividend yield is negligible at 0.07%.
AI Analysis
Linde India is precisely the kind of business I admire, but at ₹7,232.50, the price is anything but attractive. Industrial gases have sticky customers, high entry barriers, and a near-monopoly structure; promoter holding of 75% and negligible debt of 0.02 are reassuring. The balance sheet is fortress-like: Altman Z-Score of 8.57, Piotroski F-Score of 8/9, ROCE of 16.90% and ROE of 15.44%. Financially, it earns good returns while using almost no leverage. Yet valuation is the ultimate test. A P/E of 98.35, P/B of 16.32, EV/EBITDA of 39.94 and PEG of 6.42 are far beyond any conservative estimate of value. Graham's number, a rough intrinsic value floor, is ₹825.88. At ₹7,232.50, the implied margin of safety is negative 714.89%. That is not investing; it is speculation in a quality wrapper. I also see contradictions. Profit jumped 34.39%, but sales declined 0.61% in the latest year; the bottom line is growing from margins and operating leverage, not broad-based revenue growth. More troubling, free cash flow is negative ₹721 Cr despite net profit of ₹192 Cr in the latest quarter. Profits that do not become cash deserve skepticism. The dividend yield of 0.07% is negligible, so shareholders rely entirely on price appreciation. A five-year revenue CAGR of 11.06% proves the business has grown well. But at this price, the future must be flawless. I would put this on my watchlist and wait for Mr. Market to offer a price that gives me a margin of safety. In the meantime, patience is the better investment.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer